Manjistha

<h3> Absolute Contraindications of Manjistha </h3> <h4>Concurrent anticoagulant or antiplatelet therapy / bleeding disorders [If you are on blood thinners or bleed easily]</h4> <ul> <li>🩸</li> <li>Recommendation: Avoid taking Manjistha supplements or extracts while on prescription anticoagulants (e.g., warfarin) or if you have an active bleeding disorder unless supervised by a clinician.</li> <li>Reasoning: Laboratory and animal studies of Manjistha fractions show inhibition of platelet aggregation (notably PAF-induced aggregation) and anti-thrombotic activity; combining this with anticoagulant/antiplatelet drugs could increase bleeding risk.</li> <li>Scientific_Study_Title: Anti-platelet activating factor property of Rubia cordifolia Linn.</li> <li>Scientific_Study_Authors: Y B Tripathi, S Pandey, S D Shukla</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8406601/</li> <li>Scientific_Study_Excerpt: <p>Paraphrased summary: In experimental work using rabbit platelets, a partially purified fraction of Rubia cordifolia inhibited platelet aggregation that was triggered by platelet-activating factor (PAF), and reduced PAF binding to platelets in a dose-dependent manner. The preparation did not inhibit thrombin-induced aggregation, suggesting a selective effect on the PAF pathway. The authors concluded that R. cordifolia contains constituents that block or desensitize PAF responses, supporting an antiplatelet mechanism that could theoretically enhance bleeding in patients already taking blood thinners or with bleeding tendencies.</p> </li> </ul> <h4>Active bleeding (e.g., heavy menstrual bleeding, hemorrhage) [If you are actively bleeding]</h4> <ul> <li>🧾</li> <li>Recommendation: Do not use Manjistha during active hemorrhage or unexplained heavy bleeding; seek medical care first.</li> <li>Reasoning: Preclinical models show anti-thrombotic and platelet-modulating effects which could impede normal clot formation and prolong bleeding during active hemorrhage.</li> <li>Scientific_Study_Title: Anti-thrombotic and pro-angiogenic effects of Rubia cordifolia extract in zebrafish</li> <li>Scientific_Study_Authors: Wen M, et al. (authors listed in PubMed entry)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/29126989/</li> <li>Scientific_Study_Excerpt: <p>Paraphrased summary: In zebrafish models of induced thrombosis, Rubia cordifolia extracts reduced thrombus formation and demonstrated dose-dependent anti-thrombotic effects while also promoting angiogenesis. Gene expression analysis indicated effects on vascular and coagulation-related markers (e.g., vWF, VEGF-A). The paper interprets these findings as demonstrating an ability of the extract to reduce clotting in vivo in this model, implying caution where intact clot formation is clinically necessary (for example, during active bleeding).</p> </li> </ul> <h4>Pregnancy and breastfeeding [If you are pregnant or nursing]</h4> <ul> <li>🤰</li> <li>Recommendation: Avoid Manjistha during pregnancy and breastfeeding due to insufficient and conflicting safety data; consult your obstetrician before any herbal use.</li> <li>Reasoning: Traditional uses include gynecological indications, and modern reviews note wide use for menstrual and uterine conditions but emphasize scarce clinical safety data - a precautionary approach is standard when safety in pregnancy is not established.</li> <li>Scientific_Study_Title: A comprehensive review of Rubia cordifolia L.: Traditional uses, phytochemistry, pharmacological activities, and clinical applications</li> <li>Scientific_Study_Authors: Wen M, Chen Q, Chen W, Yang J, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/36160419/</li> <li>Scientific_Study_Excerpt: <p>Paraphrased summary: This systematic review summarizes traditional and modern uses of Rubia cordifolia, noting broad application in gynecological disorders (abnormal uterine bleeding, dysmenorrhea) and blood-related conditions. However, the authors highlight that most pharmacological evidence is preclinical and that clinical safety, pharmacokinetics, and toxicity studies are limited or lacking. Because of the combination of traditional reproductive-system activity and sparse human safety data, the review supports caution and avoidance in pregnancy and lactation until more evidence is available.</p> </li> </ul> <h3> Relative Contraindications of Manjistha </h3> <h4>Severe liver disease or impaired liver function [If you have known liver failure or severe chronic liver disease]</h4> <ul> <li>⚠️</li> <li>Recommendation: Use only with specialist supervision; many studies suggest hepatoprotective potential but isolated reports show extracts (particularly non-root parts/fruit) may affect liver parameters - avoid unsupervised use in severe hepatic impairment.</li> <li>Reasoning: Some experiments show protective effects in toxin models, while others (fruit extract studies) reported changes in liver biomarkers and histology in animal tests, so clinical risk in advanced liver disease cannot be excluded.</li> <li>Scientific_Study_Title: Toxicity study of dibutyl phthalate of Rubia cordifolia fruits: in vivo and in silico analysis</li> <li>Scientific_Study_Authors: (authors as listed on PubMed entry)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/25926096/</li> <li>Scientific_Study_Excerpt: <p>Paraphrased summary: An experimental study on crude ethanolic extracts of R. cordifolia fruits in mice found no acute mortality at tested doses but reported statistically significant differences in body weight and changes in biochemical markers including ALT, total protein and triglycerides; histopathological liver changes were also observed relative to controls. The authors note potential toxic constituents (e.g., dibutyl phthalate identified in fruit) and recommend careful evaluation of long-term safety, especially for formulations including non-root parts.</p> </li> </ul> <h4>Long-term, high-dose use (concern for carcinogenic potential) [If considering prolonged high-dose therapy]</h4> <ul> <li>⚠️</li> <li>Recommendation: Avoid prolonged high-dose self-administration; prefer standardized short courses and professional monitoring.</li> <li>Reasoning: Some purified constituents (rubiadin, alizarin) have been associated with preneoplastic and neoplastic lesions in long-term rodent bioassays, suggesting caution with chronic high exposure.</li> <li>Scientific_Study_Title: Carcinogenic potential of alizarin and rubiadin, components of madder color, in a rat medium-term multi-organ bioassay</li> <li>Scientific_Study_Authors: Kaoru Inoue, Midori Yoshida, Miwa Takahashi, Hitoshi Fujimoto, Makoto Shibutani, Masao Hirose, Akiyoshi Nishikawa</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/19793347/</li> <li>Scientific_Study_Excerpt: <p>Paraphrased summary: In a medium-term rat carcinogenesis bioassay, dietary exposure to rubiadin (and to a lesser extent alizarin) produced increased atypical renal tubules, renal adenomas and carcinomas, and preneoplastic lesions in liver and large intestine at higher concentrations. The investigators concluded that rubiadin has carcinogenic potential in this rodent model, which raises concern about prolonged high-level exposure to certain anthraquinone constituents found in related Rubia species.</p> </li> </ul> <h4>Concurrent use with NSAIDs (analgesics) - monitor closely [If you take NSAIDs regularly]</h4> <ul> <li>💊</li> <li>Recommendation: Discuss with your clinician before combining; monitoring for enhanced analgesic or side effects may be warranted.</li> <li>Reasoning: Preclinical work indicates that Rubia cordifolia extracts can potentiate the analgesic/anti-inflammatory actions of NSAIDs in animal models, which may alter drug effect profiles.</li> <li>Scientific_Study_Title: Variable potentiation of analgesic anti-inflammatory activity of diclofenac by two medicinal plants Rubia cordifolia and Cassia fistula in Wistar albino rats</li> <li>Scientific_Study_Authors: Rajashekar Y. R., Shobha S. N.</li> <li>Scientific_Study_Link: https://www.ijbcp.com/index.php/ijbcp/article/view/1477</li> <li>Scientific_Study_Excerpt: <p>Paraphrased summary: In rodent models, co-administration of Rubia cordifolia root preparations with sub-anti-inflammatory doses of diclofenac altered pain and inflammation outcomes compared to diclofenac alone, indicating a variable potentiation effect. The authors observed changes in pain response times and edema measures, suggesting that Rubia cordifolia may influence the pharmacodynamic profile of NSAIDs in experimental systems and supporting caution when combining in humans until clinically studied.</p> </li> </ul>